Document Detail


Cardiogenic shock: 'going to the mat'--is it needed and does it work?
MedLine Citation:
PMID:  9447304     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cardiogenic shock remains a highly lethal event. Fortunately, recent data indicate that some of these high risk patients derive particular survival benefit from aggressive treatment strategies. As yet, there are no randomized trial data, although two trials are currently being performed. Selection bias can affect results, as pointed out by Hockman et al., who found that selection for angiography was associated with improved outcome irrespective of whether revascularization was performed. That not withstanding, in aggregate, the expanding data set indicates that the outcome of cardiogenic shock can be improved with measures to raise blood pressure (therapy improving coronary perfusion), restore persistent flow to the infarct territory (PTCA, stents, or coronary bypass graft surgery) or support the circulation more optimally. The wider spread use of stents may be particularly important. Preliminary data indicate that stenting improves outcome compared to conventional PTCA using the endpoints of TIMI 3 flow, reocclusion, and mortality. Accordingly, stents and other aggressive therapy may be particularly important. These measures will not result in immortality for all patients with cardiogenic shock but do show that the high mortality can be significantly reduced in carefully selected patients. Intense efforts are underway to identify those patients at risk for developing shock or those patients who could benefit from 'going to the mat' with expensive resources to optimize outcome.
Authors:
D R Holmes; E J Topol
Related Documents :
8574054 - Percutaneous left ventricular assist system using a modification of the dennis method: ...
15258624 - Isolated right ventricular infarction mimicking anterior myocardial infarction presenti...
8466334 - Myocardial performance after contusion with concurrent hypovolemia.
19047544 - Cardiac function in pediatric septic shock survivors.
23316794 - Modulation of c(16:0) -ceramide in hypertrophied immature hearts by losartan.
16617914 - Perioperative beta blockade in noncardiac surgery: a review of the literature.
Publication Detail:
Type:  Editorial    
Journal Detail:
Title:  European heart journal     Volume:  18     ISSN:  0195-668X     ISO Abbreviation:  Eur. Heart J.     Publication Date:  1997 Dec 
Date Detail:
Created Date:  1998-03-18     Completed Date:  1998-03-18     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1839-40     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Clinical Trials as Topic
Humans
Myocardial Infarction / complications
Shock, Cardiogenic / complications,  therapy*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Stimulation by urocortin of growth hormone (GH) secretion in GH-producing human pituitary adenoma ce...
Next Document:  Can drug effects on mortality in heart failure be predicted by any surrogate measure?